These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9372069)
1. The molecular basis of the sideroblastic anemias. Fitzsimons EJ; May A Curr Opin Hematol; 1996 Mar; 3(2):167-72. PubMed ID: 9372069 [TBL] [Abstract][Full Text] [Related]
2. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia. Fujiwara T; Harigae H Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397 [TBL] [Abstract][Full Text] [Related]
3. [Heme biosynthesis and iron metabolism]. Furuyama K; Sassa S Seikagaku; 2003 Mar; 75(3):179-86. PubMed ID: 12704838 [No Abstract] [Full Text] [Related]
4. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140 [TBL] [Abstract][Full Text] [Related]
5. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia. Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial iron metabolism and sideroblastic anemia. Sheftel AD; Richardson DR; Prchal J; Ponka P Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149 [TBL] [Abstract][Full Text] [Related]
7. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine. Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495 [TBL] [Abstract][Full Text] [Related]
16. [Molecular pathophysiology of sideroblastic anemia]. Fujiwara T Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500 [TBL] [Abstract][Full Text] [Related]
17. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104 [TBL] [Abstract][Full Text] [Related]
18. Sideroblastic anaemia. May A; Fitzsimons E Baillieres Clin Haematol; 1994 Dec; 7(4):851-79. PubMed ID: 7881157 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018 [TBL] [Abstract][Full Text] [Related]
20. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia. Daher R; Mansouri A; Martelli A; Bayart S; Manceau H; Callebaut I; Moulouel B; Gouya L; Puy H; Kannengiesser C; Karim Z Mol Genet Metab; 2019 Nov; 128(3):342-351. PubMed ID: 30660387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]